{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-018053","form_type":"8-K","ticker":"CLB","cik":"0001958086","company_name":"Core Laboratories Inc. /DE/","filed_at":"2023-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.621086+00:00","generated_at":"2026-06-15T18:06:54.049657+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Core Labs issues $50M in senior secured notes at 7.25%-7.50% to refinance debt","bullets":["$25M of 7.25% notes due 2028 and $25M of 7.50% notes due 2030 placed privately.","Net proceeds to pay down existing credit facility and toward 2011 Senior Notes due Sept 2023.","Notes are senior secured, rank pari passu with existing senior debt; covenants include coverage and leverage ratios.","Closing expected on or about June 28, 2023; interest payable semi-annually starting Sept 28, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-018053","json":"https://secwatch.observer/filing/0000950170-23-018053.json","markdown":"https://secwatch.observer/filing/0000950170-23-018053.md","text":"https://secwatch.observer/filing/0000950170-23-018053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958086/000095017023018053/0000950170-23-018053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958086/000095017023018053/clb-20230504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T18:06:54.049657+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9430c405134d8bc0715c0cc10da407cb9e42adac","claim":"Core Laboratories Inc. /DE/ incurred senior notes of $50 million in aggregate principal amount with purchasers of the Notes at 7.25% and 7.50% maturing 2028 and 2030.","evidence_excerpt":"On May 4, 2023, Core Laboratories Inc. (the “Company”) and Core Laboratories (U.S.) Interests Holdings, Inc. (the “Issuer”) completed a private placement of $50 million in aggregate principal amount of the Issuer’s senior secured notes with $25 million due 2028 (the “2028 Notes”) at an interest rate of 7.25% and $25 million due 2030 (the “2030 Notes”) at an interest rate of 7.50%.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1958086/000095017023018053/0000950170-23-018053-index.htm","confidence":0.95,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"senior notes"},{"label":"Principal","value":"$50 million in aggregate principal amount"},{"label":"Counterparty","value":"purchasers of the Notes"},{"label":"Rate","value":"7.25% and 7.50%"},{"label":"Maturity","value":"2028 and 2030"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"3d7f302453547a958a2bfe890ef3c73121cd63fe","claim":"Core Laboratories Inc. /DE/ entered into Note Purchase Agreement with the purchasers of the Notes valued at $50 million (effective 2023-05-04).","evidence_excerpt":"The terms of the Notes are governed by a Note Purchase Agreement dated May 4, 2023 (the “Agreement”), between the Company, the Issuer and the purchasers of the Notes.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1958086/000095017023018053/0000950170-23-018053-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"the purchasers of the Notes"},{"label":"Value","value":"$50 million"},{"label":"Effective","value":"2023-05-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}